Actions of the novel oral antidiabetic agent HQL-975 in insulin-resistant non-insulin-dependent diabetes mellitus model animals (Q42462987)

1 November 2017

title

Actions of the novel oral antidiabetic agent HQL-975 in insulin-resistant non-insulin-dependent diabetes mellitus model animals (English)

1 reference

1 November 2017

1 reference

1 reference

Ishikawa Y

1 reference

1 November 2017

Saito MN

1 reference

1 November 2017

Ikemoto T

1 reference

1 November 2017

Takeno H

1 reference

1 November 2017

Watanabe K

1 reference

1 November 2017

Tani T

1 reference

1 November 2017

publication date

1 August 1998

1 reference

Diabetes Research and Clinical Practice

1 November 2017

published in

1 reference

1 November 2017

1 reference

1 November 2017

1 reference

1 November 2017

page(s)

101-111

1 reference

An Epidemiologic Model for Diabetes Mellitus: Incidence, Prevalence, and Mortality

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Antiobesity and antidiabetic actions of a new potent disaccharidase inhibitor in genetically obese-diabetic mice, KKA(y)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Antidiabetic agent englitazone enhances insulin action in nondiabetic rats without producing hypoglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Hexokinase and glucokinase distribution in the liver lobule

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Pyruvate kinases from human erythrocytes and liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

An activation factor of liver phosphofructokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

The mechanism of histone activation of the hepatic microsomal glucose-6-phosphatase system: a novel method to assay glucose-6-phosphatase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

In vivo and in vitro phosphorylation of rat liver fructose-1,6-bisphosphatase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Sympathetic activation of glucose utilization in brown adipose tissue in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Antihyperglycemic activity of novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

General Survey of Diabetic Features of Yellow KK Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Alterations of hepatic enzyme activities in KK and yellow KK mice with various diabetic states

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Abnormalities in hepatic enzyme activities during development of diabetes in db mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Hepatic glycolytic and gluconeogenic enzymes of the obese-hyperglycemic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2898%2900080-1

7 January 2021

10.1016/S0168-8227(98)00080-1

Identifiers

DOI

1 reference

1 November 2017

1 reference